Sanara MedTech grants 2,804 restricted shares

Mackey Ashley M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Mackey Ashley M reported acquisition or exercise transactions in this Form 4 filing.

Sanara MedTech Inc. reported that Controller Ashley M. Mackey received a grant of 2,804 shares of restricted common stock at no cash cost under the company’s 2024 Omnibus Long-Term Incentive Plan. The restricted stock vests in three equal installments on March 22 of 2027, 2028 and 2029, if she remains employed on each date.

The amended Form 4 corrects her post‑grant holdings to 4,967 common shares, revising an earlier filing that had overstated the amount as 5,067 shares.

Insider Trade Summary

Grant/Award: 2,804 shares

Grant/Award 1 txn

Insider Mackey Ashley M

Role Controller

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,804	$0.00	$0.00

Holdings After Transaction: Common Stock — 4,967 shares (Direct)

Footnotes (2)

1. F1. Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.
2. F2. The original Form 4, filed on March 23, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of the Issuer reported as being beneficially owned by the reporting person. The original Form 4 mistakenly indicated that the reporting person held 5,067 shares of common stock, when in fact, as reported in this amendment, the reporting person held 4,967 shares of common stock following the reported transaction.

Key Figures

Restricted stock grant: 2,804 shares Grant price: $0.0000 per share Shares owned after grant: 4,967 shares +3 more

6 metrics

Restricted stock grant 2,804 shares Common stock awarded on March 22, 2026

Grant price $0.0000 per share Equity compensation, no cash paid by insider

Shares owned after grant 4,967 shares Common stock beneficially owned following transaction

Vesting schedule year 1 One-third of 2,804 shares Vests March 22, 2027, if still employed

Vesting schedule year 2 One-third of 2,804 shares Vests March 22, 2028, if still employed

Vesting schedule year 3 One-third of 2,804 shares Vests March 22, 2029, if still employed

Key Terms

restricted stock, 2024 Omnibus Long-Term Incentive Plan, beneficially owned, vest

4 terms

restricted stock financial

"Represents shares of restricted stock granted by Sanara MedTech Inc."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

2024 Omnibus Long-Term Incentive Plan financial

"pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan."

beneficially owned financial

"to reduce the number of shares of common stock of the Issuer reported as being beneficially owned by the reporting person."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

vest financial

"The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sanara MedTech (SMTI) report for Ashley M. Mackey?

Sanara MedTech reported that Controller Ashley M. Mackey received a grant of 2,804 shares of restricted common stock. The award was issued at no cash cost as part of equity compensation, increasing her beneficial ownership to 4,967 common shares following the reported transaction.

How do the 2,804 SMTI restricted shares granted to Ashley M. Mackey vest?

The 2,804 restricted shares vest in three equal installments over three years. One-third of the shares vest on March 22, 2027, another third on March 22, 2028, and the final third on March 22, 2029, contingent on her continued employment with Sanara MedTech.

Why did Sanara MedTech file an amended Form 4/A for Ashley M. Mackey?

Sanara MedTech filed the amended Form 4/A to correct the number of common shares reported as beneficially owned. The original Form 4 showed 5,067 shares after the transaction, but the amendment clarifies that Ashley M. Mackey actually held 4,967 common shares following the grant.

What is Ashley M. Mackey’s role at Sanara MedTech (SMTI) and how many shares does she own?

Ashley M. Mackey serves as Controller at Sanara MedTech. After receiving the 2,804-share restricted stock grant reported in this filing, she beneficially owns 4,967 shares of the company’s common stock, reflecting the corrected total disclosed in the amended Form 4/A.

Under which plan were the 2,804 Sanara MedTech restricted shares granted?

The 2,804 restricted shares were granted under the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. This plan provides equity-based awards, such as restricted stock, designed to align employee compensation with company performance over time through multi-year vesting schedules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/05/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mackey Ashley M

(Last) (First) (Middle)

1200 SUMMIT AVE

SUITE 414

(Street)

FORT WORTH TEXAS 76102

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sanara MedTech Inc. [ SMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Controller

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/23/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/22/2026		A		2,804(1)	A	$0(1)	4,967(1)(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.

2. The original Form 4, filed on March 23, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of the Issuer reported as being beneficially owned by the reporting person. The original Form 4 mistakenly indicated that the reporting person held 5,067 shares of common stock, when in fact, as reported in this amendment, the reporting person held 4,967 shares of common stock following the reported transaction.

	/s/ Ashley M. Mackey	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)